Korioretinitis Toksoplasmosis pada Penderita Imunokompeten

  • Joko Anggoro Fakultas Kedokteran Universitas Mataram

Abstract

Toksoplasmosis merupakan penyakit sistemik yang disebabkan parasit protozoa koksidia Toxoplasma gondii, infeksi biasanya tanpa gejala atau muncul dalam bentuk akut dengan gejala limfadenopati atau dengan gejala menyerupai flu (flu-like symptoms). Pada infeksi primer, penderita biasanya asimtomatik dan kadang hanya bergejala seperti demam, limfadenopati dan limfositosis yang berlangsung sampai berhari-hari atau beberapa minggu. Kami akan membahas lebih dalam sebuah kasus chorioretinitis toksoplasmosis pada penderita imunokompeten baik dari gejala klinis dan terapinya

References

1. Weiss LM, & Dubey JP. Toxoplasmosis: A history of clinical observation. Int J Parasit. 2009;(39):895–901.

2. Singh D, Sinert R. Toxoplasmosis. eMedicine Emergency Medicine. 2015;Available from: www.emedicine.medscape.com.

3. Wu L, Evans T, Garcia RA. Toxoplasmosis: Overview. eMedicine Ophtalmology. 2007;Available from: www.emedicine.medscape.com.

4. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. American journal of epidemiology. 2001;154(4):357–365.

5. Holland GN. Ocular toxoplasmosis: a global reassessment:. Part I: epidemiology and course of disease. American journal of ophthalmology. 2003;136(6):973–988.

6. Kravetz JD, Federman DG. Cat-associated zoonoses. Archives of Internal Medicine. 2002;162(17):1945–1952.

7. Villarreal MR. File:Toxoplasmosis life cycleen.svg; 2010. Available from: https://commons.wikimedia.org wiki/File:Toxoplasmosis_life_cycle_en.svg#file.

8. Holland GN, Lewis KG, O’Connor GR. Ocular toxoplasmosis: a 50th anniversary tribute to the contributions of Helenor Campbell Wilder Foerster. Archives of Ophthalmology. 2002;120(8):1081–1084.

9. Suhardjo, Utomo PT, Agni AN. Clinical Manifestations Of Ocular Toxoplasmosis In Yogyakarta, Indonesia: A Clinical Review Of 173 Cases. Southeast Asian J Trop Med Public Health. 2003;2(34):291–7.

10. Holland GN. Ocular toxoplasmosis: a global reassessment: part II: disease manifestations and management. American journal of ophthalmology. 2004;137(1):1–17.

11. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clinical microbiology reviews. 2000;13(4):662–685.

12. Holland GN, Crespi CM, ten Dam-van Loon N, Charonis AC, Yu F, Bosch-Driessen LH, et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. American journal of ophthalmology. 2008;145(6):1007–1013.

13. Eckert G, Melamed J, Menegaz B. Optic nerve changes in ocular toxoplasmosis. Eye. 2007;21(6):746–751.

14. Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. American journal of ophthalmology. 2008;146(6):856–865.

15. Gray H. Anatomy of the Human Body; 2000. Available from: http://www.bartleby.com/107/.

16. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. Journal of clinical microbiology. 2004;42(3):941–945.

17. Paul M. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clinical and diagnostic laboratory immunology. 1999;6(4):514–518.

18. Tayuksel M, Guney C, Araz E, Saracli MA, Doganci L. Performance of the Immunoglobulin G Avidity and Enzyme Immunoassay IgG/IgM Screening Tests for Differentiation of the Clinical Spectrum of toxoplasmosis. Journal of Microbiology. 2004;3(43):211–5.

19. Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita. 2004;40(1):81–8.

20. Torre A, Gonzalez G, D ´ ´ ıaz-Ramirez J, Gomez- ´ Mar´ ın JE. Screening by Ophthalmoscopy for Toxoplasma Retinochoroiditis in Colombia. Am J Ophthalmol. 2007;(143):354 –6.

21. Villard O, Filisetti D, Roch-Deries F, Garweg J, Flament J, Candolfi E. Enzyme-Linked Immunosorbent Assay, Immunoblotting, and PCR for Diagnosis of Toxoplasmic Chorioretinitis. J Clin Microbiol. 2003;8(41):3537–41.

22. Hajj-Ali RA, Lowder C, Mandell BF. Uveitis in the internist’s office: are a patient’s eye symptoms serious. Cleve Clin J Med. 2005;72(4):329–39.

23. Stanford MR, See SE, Jones LV, Gilbert RE. Antibiotics for toxoplasmic retinochoroiditis: An evidence-based systematic review. Ophthalmology.
2003;(110):926–32.

24. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis 1, 2. Elsevier; 2002.

25. Bovey EH. Usefulness of vitrectomy in the treatment of ocular toxoplasmosis. International journal of medical sciences. 2009;6(3):139.

26. Guex-Crosier Y. Update on the treatment of ocular toxoplasmosis. Int J Med Sci. 2009;6(3):140–2.

27. Soheilian M, Sadoughi MM, Dehghan MH, Behboudi H, Anisian A, Yazdani S. Prospective Randomized Trial of Trimethoprim/Sulfamethoxazole
versus Pyrimethamine and Sulfadiazine in the Treatment of Ocular Toxoplasmosis. Am Ac Ophtalmol.2005;(112):1876–82.

28. Rothova A, Bosch-Driessen LE, Van Loon NH, Treffers WF. Azithromycin for ocular toxoplasmosis. British journal of ophthalmology. 1998;82(11):1306–1308.

29. Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS, van Ruyven RL, Klok AM, Hoyng CB, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. American journal of ophthalmology. 2002;134(1):34–40.

30. Ng P, McCluskey P. Treatment of ocular toxoplasmosis. Australian Prescriber. 2002;25(4):88–89.
Published
2017-03-23
Section
Case Report